Skip to content
    REGN stock page

    REGENERON PHARMACEUTICALS, INC.

    REGN · earnings call history

    5 calls analysed
    1. Mar 2026Q1 FY26Apr 29, 2026

      Regeneron Q1 FY26 — Strong Commercial Execution and Pipeline Progress

      Read the brief
    2. Dec 2025Q4 FY25Jan 30, 2026

      Regeneron Q4 FY25 — Strong Commercial Execution and Robust Pipeline Advancement

      Read the brief
    3. Sep 2025Q3 FY25Oct 28, 2025

      Regeneron Q3 FY25 — Strong Product Growth and Pipeline Advancements Amid Regulatory Headwinds

      Read the brief
    4. Mar 2025Q1 FY25Apr 29, 2025

      Regeneron Q1 FY25 — Mixed Performance with EYLEA Headwinds Offset by Dupixent Growth and Pipeline Progress

      Read the brief
    5. Dec 2024Q4 FY24Feb 04, 2025

      Regeneron Q4 FY24 — Strong Dupixent Growth, EYLEA HD Uptake, and Pipeline Progress

      Read the brief

    Browse all US companies on the earnings-call register.